
Edison Group Research Report
Edison has released a report on LTR Pharma, highlighting the clinical validation of SPONTAN as a fast-acting intranasal treatment for erectile dysfunction and its progression toward regulatory submission. The report also covers our platform expansion into new markets through ROXUS and OROFLOW, alongside portfolio diversification via our recent investment in

